Embryonic stem cells go from bench to bedside for Parkinson's disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33948581.
- Also identified by DOI 10.1016/j.xcrm.2021.100251 and PMC identifier 8080240.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Stem-cell-derived transplants may soon be a promising treatment option for Parkinson's disease. In preparation for clinical trial, Piao et al.<sup>1</sup> report on generating a clinical-grade dopaminergic progenitor cell product and its rigorous testing to ensure safety and efficacy.
Medical subject headings
- Parkinson Disease